ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

Neutron Answers Needed Soon, Kligerman Says

May 6, 1983

Senate Appropriations Committee Earmarks $118 Million for Centers, Orders Full Grant Funding

October 9, 1987

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

September 18, 2009